You just read:

Charleston Laboratories, Inc. Reacquires Rights to Novel Investigational Treatment CL-108, for Acute Pain and Opioid-Induced Nausea and Vomiting

News provided by

Charleston Laboratories, Inc.

Aug 31, 2017, 08:00 ET